Welcome to the 9th Advanced RWE Applications in Pharma

Creating Value for Patients through Extrapolating Real-World Clinical & Behavioral Data

Returning for its 9th year, Advanced Real-World Evidence Applications in Pharma 2021 (formerly IMPACCT: RWE) will assist pharma and biotech leaders in transforming real-world evidence into business intelligence, impacting your pipeline, and delivering patient outcomes.

This comprehensive industry-led forum is dedicated to revolutionizing novel treatment development through RWE applications: re-strategizing clinical programs, maximizing product lifecycles, and minimizing risks.

Across 3 days, you can expect 18+ practical case studies and a collaborative, open discussion to accelerate your implementation of real-world evidence approaches to enhance clinical R&D outcomes, de-risk clinical trials, and maximize product lifecycle.

What’s New in 2021?

2020 was an exciting year for real-world data (RWD) and real-world evidence (RWE) experts within pharma and biotech. The FDA’s high-profile acceptance of RWD as part of their review for COVID-19 treatments and vaccines for emergency use authorization was a big moment for the industry. This is now energizing RWD and RWE into R&D and clinical activities – expediting novel treatments for patients and substantially reducing drug developers’ R&D spend.

However, major questions still need answers urgently. The 9th Advanced Real-World Evidence Applications in Pharma will return in October 2021 to delve into the core industry challenges, including:

  • Assessing the global regulatory environment for future RWE application
  • Advanced data acquisition and analytics to enable your R&D and clinically informed decision making
  • Leverage RWE in your clinical activities – from patient selection to synthetic trial arm
  • How to create a robust, regulatory-compliant RWE framework and data package for your successful IND filing
  • Maximizing your product lifecycle through a comprehensive observational data program
    Establishing pre-competitive collaboration to deepen your understanding of diseases, offering patients a personalized and effective treatment through RWE & RWD

Your Expert Speakers

Charles Makin

Global Head, Medical Health Outcomes

Biogen

Eric Sarpong

Director Real World Data Analytics & Innovation, Center for Observational & Real World Evidence

Merck

Kraig Kinchen

Senior Director, Center of Expertise, Global Patient Outcomes & Real World Evidence

Eli Lilly

Robertino Mera-Giler

Head Biostatistics, Epidemiology, RWE

Freenome Inc.

What people thought at the 8th IMPACCT: RWE

"Perfect! I would like to see IMPACTT:RWE next year again”

Past Attendee

“Great insight of the RWE environment”

Past Attendee